drugset / Trial / NCT01146119
Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multi-center, randomized, two stage, double-blind, placebo-controlled administration study comprising 200 healthy participants.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-05
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Multimeric-001 | Vaccine | 500 ug | Intramuscular |
| Comparator | TIV | Vaccine | 15 % | Intramuscular |
| Comparator | TIV | Vaccine | 50 % | Intramuscular |